1) Wei JT, et al : Urologic Diseases in America Project : Benign Prostatic Hyperplasia. J Urol 179 : S75-S80, 2008
2) Boyle P, et al : The Prevalence of Lower Urinary Tract Symptoms in Men and Women in Four Centers. The UrEpik Study. BJU Int 92 : 409-414, 2003
3) Singla N, et al : Evaluation and Management of Lower Urinary Tract Symptoms After Outlet Surgery for Benign Prostatic Hyperplasia. Curr Bladder Dysfunct Rep 11 : 242-247, 2016
4) Nitti VW, et al : Voiding Dysfunction Following Transurethral Resection of the Prostate : Symptoms and Urodynamic Findings. J Urol 157 : 600-603, 1997
5) Tkocz M, et al : Comparison of Long-Term Results of Transurethral Incision of the Prostate with Transurethral Resection of the Prostate, in Patients with Benign Prostatic Hypertrophy. Neurourol Urodyn 21 : 112-116, 2002
6) Kuo HC : Analysis of the Pathophysiology of Lower Urinary Tract Symptoms in Patients After Prostatectomy. Urol Int 68 : 99-104, 2002
7) Mirone V, et al : The Detrusor Muscle : An Innocent Victim of Bladder Outlet Obstruction. Eur Urol 51 : 57-66, 2007
8) Porreca A, et al : Perioperative Outcomes of Holmium Laser Enucleation of the Prostate : A Syetematic Review. Urol Int 21 : 1-13, 2021
Urinary Incontinence Following Holmium Laser Enucleation of the Prostate. Neurourol Urodyn 30 : 1343-1349, 2011
10) Cho MC, et al : Change in Storage Symptoms Following Laser Prostatectomy : Comparison Between Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP). World J Urol 33 : 1173-1180, 2015
11) Sandhu JS, et al : Incontinence After Prostate Treatment : AUA/SUFU Guideline. J Urol 202 : 369-378, 2019
12) Allameh F, et al : Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin ― A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder : A Case-Control Study. Clin Pharmacol 12 : 75-81, 2020
13) Chughtai B, et al : Randomized, Double-Blind, Placebo Controlled Pilot Study of Intradetrusor Injections of OnabotulinumtoxinA for the Treatment of Refractory Overactive Bladder Persisting Following Surgical Management of Benign Prostatic Hyperplasia. Can J Urol 21 : 7217-7221, 2014